|
Home
What is
Hepatitis
How is it
Transmitted
Long Term
Prognosis
Complications of
HCV
Liver
Biopsy
Treatment Info
(Interferon, Herbal, etc)
Lab Tests (PCR,
Genotype,etc.)
Nutrition
& Alternative Info
Patient
Information (Support Groups, Doctor Listing,
etc)
Related
Webpages
Transplant
Info
Site
Search
HCV
Webrings
My
guestbookbook
Site
Awards
FAQ &
Disclaimers
|
HCV-RNA levels play an important role independently of genotype
in predicting response to interferon therapy
Author: Picciotto A, Campo N, Brizzolara R, Sinelli N, Poggi G,
Grasso S, Celle G, Department of Internal Medicine, University of
Genoa, Italy.
Source: Eur J Gastroenterol Hepatol 9: 67-69 (1997)
OBJECTIVE:
To evaluate the relationship between hepatitis C virus (HCV)-RNA
levels and genotypes in order to establish their potentially
predictive role in interferon (IFN) response.
DESIGN:
To detect HCV genotype at baseline and HCV viraemia levels before
and during IFN treatment in three groups of patients with different
IFN response.
METHODS:
Our study included 85 patients with biopsy-proven chronic hepatitis
C who underwent IFN therapy at standard schedule (3 MU thrice
weekly for 6 months). On the basis of IFN response they were
subdivided into three groups as follows: non responders (NR: 27
cases) when alanine aminotransferase (ALT) values (normal value:
0-40 IU) at the end of treatment were abnormal (101.7 +/- 10.4);
responders relapsing (RR: 29 cases) when normal ALT values at the
end of therapy (28.14 +/- 1.7) increased during follow-up;
sustained (long-term) responders (LTR: 29 cases) when ALT values
remained normal for at least 12 months of follow-up (ALT values at
the end of therapy: 21.8 +/- 1.4). ALT activity was monitored
monthly during therapy and each month during 12 months of
follow-up. HCV genotype was evaluated before starting treatment
whereas HCV-RNA viraemia was checked at baseline and at the 1st and
6th months of therapy. RESULTS: The baseline viral load was higher
in the NR group than in the RR and LTR groups independently of
genotype; HCV-RNA levels progressively decreased during therapy
independently of response but the levels remained significantly
higher in the NR group. Genotype 1b was prevalent in the NR group.
However, levels of viraemia in genotype 1b LTR patients are
significantly lower than in genotype 1b NR patients.
CONCLUSION:
These results suggest that among viral-related parameters viraemia
alone seems to play an important role in predicting response to IFN
independently of genotype.
Home | What is HCV | Transmission |
Future |
Complications |
Biopsy |
Treatment
| Lab |
Nutrition |
Patient |
Links | Transplant |
Webrings |
guestbookbook |
Awards |
FAQ
|
|